ArticleOncotarget2015

ψ-Bufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling.

Jin Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.